Novartis Drug Investigated After 11 Deaths

Novartis Drug Investigated After 11 Deaths
World

A multiple sclerosis drug made by industry giant Novartis is under investigation after at least 11 patients taking the medicine died.

The drug, Gilenya, was licensed last year in the European Union to treat patients with a severe type of multiple sclerosis.

The deaths raise concerns Gilenya could trigger heart problems after patients take their first dose, according to a statement issued Friday by the European Medicines Agency. The agency, which is now investigating the drug, said it isn’t clear if it caused the deaths.

One of the deaths was in the U.S., where a patient died within 24 hours of taking the first dose.

The European agency said it didn’t know where the other 10 deaths occurred, but that they were reported to its drug database, which monitors side effects from medicines in the European Union.

A spokeswoman at the U.S. Food and Drug Administration said it also is conducting a data analysis but has not made any definitive conclusions and does not know when its review will be complete.

More than 30,000 patients have taken Gilenya worldwide. The European Medicines Agency advised doctors to increase their monitoring of patients after the first dose of the medicine. The agency said the risk of a slow heart rate after the first dose of Gilenya was known when it was approved.

Novartis AG said it was advising doctors of new recommendations on using Gilenya. They include continuous heart monitoring during the first six hours after patients take their first dose and measuring their blood pressure and heart rate every hour. This new guidance applies only to patients taking their first dose, Novartis said in a statement.

The EU drug regulator hopes to finish its review of the drug by March.

Associated Press

Share Tweet
React
Like Us On Facebook
Like Us On Facebook

Preston Waters

Preston Waters is a thinker. He's not your traditional philosophical persona, however, as he leaves no topic untouched. Covering all the bases, from business to women, Preston Waters is the ultimate man's man for Gen-Y.

Original Video

Everything You Need To Know About Marijuana

Jesus has risen, but how high did he get? While Easter and 4/20 falling on the same day is most definitely a weird coincidence, it will also highlight a pretty important public opinion on what’s more important: weed or candy eggs? Sto...

More In World

World Connor Toole

Ukranian Man Offers $10k Each For Capture Of Russian Invaders

A Ukrainian politician has put a bounty on the head of Russian mercenaries in an attempt to stymie the neighboring country’s hostile actions in the region. According to The Trumpet, Borys Filatov, the lieutenant governor of Dnipropetrovsk, posted a message to Facebook earlier this week in which he provided a number of incentives for anyone […]

World Sean Levinson

The Flyer About Jews Needing To Register In East Ukraine Is Thankfully Fake

Western intervention in Ukraine seemed like a distinct possibility yesterday when it was reported that the Jewish community in the eastern city of Donetsk, currently occupied by pro-Russian militants, was given leaflets saying that they would be deported if they did not register with what is calling itself the city’s temporary government. But according to […]

World Sean Levinson

The Underwater Search For MH370 Could Cost A Quarter Billion Dollars

An underwater vehicle made by a private American company is currently searching for missing Malaysia Airlines Flight 370. It has come up with nothing after four missions covering nearly 50 square miles of sea. If the US continues employing private companies to search for the plane, it could cost a quarter of a billion dollars. […]

Also On Elite

Wellness

14 Of Life’s Toughest Moments That Time Will Always Cure

“You’ll feel better in the morning.” We’ve all heard the statement and we most likely have been on the other end of it at least once. As we lie crying or hurting, we’re always reassured that everything will be better in the light of morning. Tomorrow will be a new day and the pain will […]